Theromics Revenue and Competitors
Estimated Revenue & Valuation
- Theromics's estimated annual revenue is currently $1.7M per year.
- Theromics's estimated revenue per employee is $121,429
- Theromics's total funding is $4M.
Employee Data
- Theromics has 14 Employees.
- Theromics grew their employee count by 100% last year.
Theromics's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Co-Founder & Chief Medical Officer | Reveal Email/Phone |
3 | C.E.O. | Reveal Email/Phone |
Theromics Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $137.2M | 288 | 28% | N/A | N/A |
#2 | $7.5M | 17 | 0% | N/A | N/A |
#3 | $2.7M | 12 | 20% | N/A | N/A |
#4 | $0.1M | 4 | -20% | N/A | N/A |
#5 | $5.6M | 21 | 17% | $28.9M | N/A |
#6 | $7.5M | 118 | 4% | N/A | N/A |
#7 | $7.5M | 76 | 33% | N/A | N/A |
#8 | $4.2M | 25 | 14% | N/A | N/A |
#9 | $1.4M | 18 | 50% | N/A | N/A |
#10 | $17.9M | 52 | 16% | N/A | N/A |
What Is Theromics?
Theromics has developed a novel, safe, Thermal Accelerant (TA) called HeatSYNC TA. The HeatSYNC TA is used during microwave and radiofrequency ablations of cancerous tumors. HeatSYNC can augment the reach of thermal energy from a distance normally unattainable by microwave or radiofrequency devices, thus high-power energy is not needed. “Caution: This device is for Investigational Use Only and has not been cleared by the FDA or other regulatory bodies.”
keywords:N/A$4M
Total Funding
14
Number of Employees
$1.7M
Revenue (est)
100%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7M | 28 | 22% | N/A |
#2 | $5.8M | 32 | 0% | N/A |
#3 | $7.1M | 33 | 0% | N/A |
#4 | $1.7M | 43 | 39% | N/A |
#5 | $10.9M | 47 | 9% | N/A |